Status: Recruiting
Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection
This study aims to compare the eradication rate, safety, and patient adherence between potassium-competitive acid blockers (P-CABs) and proton pump inhibitor-based bismuth quadruple therapy in patients with Helicobacter pylori infection.
Participants needed: 320
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Tanta UniversityUpdated: Sep 12, 2025Locations: 1
Eligibility criteria
Adults aged ≥18 years. [+3]
Prior Helicobacter pylori treatment. [+5]